Biotech manufacturer recommended for continued certification to ISO 9001:2015 and ISO 13485:2016 Madison, WI USA. -- Promega Corporation announced today it successfully completed its first ever fully remote quality surveillance assessment and is recommended for continued certification to ISO 9001:2015 and ISO 13485:2016. Due to COVID-19 restrictions, the British Standards Institution (BSI) completed its six-day review [...]

Accelerates the detection and identification of viral sequences and seamless submission to critical databases SAN DIEGO--Illumina, Inc. (NASDAQ: ILMN) announces the Illumina SARS-CoV-2 Data Toolkit, a new suite of data analysis tools and workflow functionality for researchers working with the virus using next-generation sequencing (NGS). The toolkit makes it easier for researchers to detect and [...]

Sino Biological, Inc. today announced a co-development agreement with Nanommune Inc., an Irvine, California based biotechnology company specializing in the development and application of multiplex array technology. Under the terms of the agreement, the two companies will jointly develop coronavirus antigen array products for serological studies of COVID-19 and other infectious diseases. The two companies also [...]

LexaGene Files Patent Application for Expanded Capabilities of Their LX Analyzer To meet higher COVID-19 testing needs in reference laboratories   BEVERLY, Mass. – LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, announced today the filing of a provisional patent application [...]

Schauenburg Analytics has announced that Thierry Faye has been appointed Group Marketing Director. Faye, previously Director of Agilent’s Global Market Development organization, brings to Schauenburg Analytics a wealth of sales and marketing experience across the GC and GC-MS marketplace, as it continues its journey as a world-leading manufacturer of powerful analytical products and workflows across [...]

Schauenburg Analytics has announced that Thierry Faye has been appointed Group Marketing Director. Faye, previously Director of Agilent’s Global Market Development organization, brings to Schauenburg Analytics a wealth of sales and marketing experience across the GC and GC-MS marketplace, as it continues its journey as a world-leading manufacturer of powerful analytical products and workflows across [...]

Enhancing our business in the bioeconomy market - Tokyo, Japan - Yokogawa Electric Corporation (TOKYO: 6841) announces that on April 8, it completed the acquisition of all shares of Fluid Imaging Technologies, Inc., as mutually agreed. Fluid Imaging Technologies possesses advanced technologies and know-how in the analysis of cells and other types of particles suspended [...]

Researchers at the Cancer Institute, University College London, are using INTEGRA’s unique electronic pipette range to simplify their workflows. Yvette Hoade, a research technician in the Payne Laboratory, Department of Haematology, is investigating mutations associated with various blood diseases such as bone marrow failure and myelodysplastic syndrome (MDS), both age-related disorders that greatly increase the risk [...]

Combined Application of PBI's Pressure Cycling Technology and RSB's Microfluidic Modulation Spectroscopy Reveals Accurate Details of Protein Structure, Folding, and Aggregation Critical to Development, Manufacture, and Quality Control of Next Generation Treatments SOUTH EASTON, Massachusetts -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, [...]

Novel CL7/Im7 system enables rapid, high-purity, high-yield production of Coronavirus S-Spike proteins for research BIRMINGHAM, Ala. – Researchers at the Earle A. Chiles Research Institute, a division of Providence Cancer Institute, are using TriAltus Bioscience, LLC protein purification technology to fast-track development of an ELISA test to monitor antibody responses to SARS-CoV-2 in patients that will receive [...]